<?xml version="1.0" encoding="UTF-8"?>
<p id="Par12">The frequency of resistance in seasonal A/H1N1 viruses increased from 2005 to 2007, primarily due to the Ser31Asn mutation [
 <xref ref-type="bibr" rid="CR29">29</xref>, 
 <xref ref-type="bibr" rid="CR30">30</xref>]. Fortunately, the incidence of primary resistance declined in 2008 and 2009 among seasonal A/H1N1 viruses as oseltamivir-resistant viruses predominated [
 <xref ref-type="bibr" rid="CR44">44</xref>]. This seasonal A/H1N1 virus, which was replaced by the 2009 pandemic A/H1N1 virus, was primarily resistant to the M2 inhibitors generally due to the Ser31Asn mutation [
 <xref ref-type="bibr" rid="CR44">44</xref>]. As a result, all currently circulating strains of influenza A are primarily resistant to the M2 inhibitors, and this class of drug is not recommended for the prevention or treatment of influenza [
 <xref ref-type="bibr" rid="CR2">2</xref>].
</p>
